Decitabine Injection shortage
Decitabine Injection is currently listed in shortage by the FDA. The FDA lists 2 affected products. This page was last refreshed from FDA data on Oct 5, 2026.
BluePoint Laboratories is permanently stopping its decitabine injection 50 mg. Other makers — including Hikma, Accord Healthcare, Sagent, and Camber — still list this medicine as available.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Decitabine Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Feb 20, 2026Currently in shortage2 of 2 products affected.
-
Feb 20, 2026First reported to the FDA2 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Ingenus Pharmaceuticals LLC 📞 866-321-5031 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Decitabine, Injection, 50 mg (NDC 50742-430-01) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Decitabine, Injection, 50 mg (NDC 68001-573-41) | — | — | Labeler: BluePoint Laboratories; Discontinuation of the manufacture of the drug | — |
These rows are manufacturer reports to the FDA for Decitabine Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Decitabine Injection? options further down this page.
Why is Decitabine Injection in shortage?
From what's been reported to the FDA, Ingenus Pharmaceuticals (which also markets this product under the BluePoint Laboratories label) is permanently stopping the manufacture of their 50 mg Decitabine Injection. This applies to both versions of the 50 mg product they make. No specific reason was shared publicly for why they made this decision — just that production is being discontinued.
It's worth knowing that this report only reflects what Ingenus/BluePoint has filed with the FDA. It speaks only to their 50 mg product being permanently pulled from production — not to every maker of decitabine out there.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Decitabine Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Decitabine Injection?
Decitabine Injection is currently on the FDA shortage list. This note is to help you understand what that means and what steps make sense next.
The affected strength is the 50 mg injection. Right now, the manufacturer on this record (listed under BluePoint Laboratories) reports no available supply of this 50 mg product. The status is listed as "to be discontinued," which means this particular supply problem may be permanent rather than a short-term gap.
Because this is a discontinuation rather than a temporary delay, the most important thing is to plan ahead with your care team. Keep in mind this report reflects only the manufacturer(s) that filed it. Several other companies make the same medicine — decitabine 50 mg injection — so it may still be obtainable from another source.
Here is what I suggest, in order:
- Do not stop or change your treatment on your own — this medicine is used under close medical supervision, so any change should come from your care team.
- Ask your pharmacy to check whether the same medicine is available from another maker, such as Hikma, Accord, Sagent, Camber, Dr. Reddy's, Eugia, Mylan, Amneal, or Meitheal; it may not be in local stock.
- If it cannot be found, talk with your prescriber about a clinician-chosen option.
Manufacturer contact numbers are listed on this page for reference, though pharmacies usually handle those calls. This is general, national information and may not match your local pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Decitabine Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Decitabine Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Decitabine | DECITABINE 50 mg/1 | Injection, Powder, Lyophilized, For Solution · Intravenous | Hikma Pharmaceuticals USA Inc. | 00143-9385-01 |
| Decitabine | DECITABINE 50 mg/20mL | Injection, Powder, Lyophilized, For Solution · Intravenous | Accord Healthcare Inc. | 16729-0224-05 |
| Decitabine | DECITABINE 50 mg/20mL | Injection, Powder, Lyophilized, For Solution · Intravenous | Sagent Pharmaceuticals | 25021-0219-20 |
| Decitabine | DECITABINE 50 mg/10mL | Injection, Powder, Lyophilized, For Solution · Intravenous | Camber Pharmaceuticals, Inc. | 31722-0304-31 |
| Decitabine | DECITABINE 50 mg/10mL | Injection, Powder, Lyophilized, For Solution · Intravenous | Dr. Reddy's Laboratories Inc. | 43598-0427-37 |
| Decitabine | DECITABINE 50 mg/10mL | Injection, Powder, Lyophilized, For Solution · Intravenous | Dr.Reddy's Laboratories Limited | 55111-0556-10 |
| Decitabine | DECITABINE 50 mg/26mL | Injection, Powder, Lyophilized, For Solution · Intravenous | Eugia US LLC | 55150-0376-01 |
| Decitabine | DECITABINE 50 mg/20mL | Injection, Powder, Lyophilized, For Solution · Intravenous | Mylan Institutional LLC | 67457-0316-25 |
| Decitabine | DECITABINE 50 mg/20mL | Injection, Powder, Lyophilized, For Solution · Intravenous | BluePoint Laboratories | 68001-0618-37 |
| Decitabine | DECITABINE 50 mg/10mL | Injection, Powder, Lyophilized, For Solution · Intravenous | BluePoint Laboratories | 68001-0642-41 |
| Decitabine | DECITABINE 50 mg/20mL | Injection, Powder, Lyophilized, For Solution · Intravenous | Amneal Pharmaceuticals LLC | 70121-1644-01 |
| Decitabine | DECITABINE 50 mg/20mL | Injection, Powder, Lyophilized, For Solution · Intravenous | Meitheal Pharmaceuticals Inc. | 71288-0119-20 |
Alternative dosage forms of Decitabine
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 22 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| decitabine 50 mg | Hikma | 1 vial | — | AP | FDA listed |
| Decitabine 50 mg/20mL | Accord | 1 vial | — | AP | FDA listed |
| Decitabine 50 mg/20mL | Sagent | 1 vial | — | AP | FDA listed |
| Decitabine 50 mg/10mL | Camber | 1 vial | — | AP | FDA listed |
| Decitabine 50 mg/10mL | Dr. | 1 vial | — | AP | FDA listed |
| decitabine | Sun | 1 kit | — | — | FDA listed |
| Decitabine 50 mg/10mL | Dr.Reddy's | 1 vial | — | AP | FDA listed |
| Decitabine 50 mg/26mL | Eugia | 1 vial | — | — | FDA listed |
| Decitabine 50 mg/20mL | Qilu | 1 vial | — | AP | FDA listed |
| Decitabine 50 mg/20mL | Mylan | 1 vial | — | AP | FDA listed |
| Decitabine 50 mg | BluePoint | 1 vial | — | — | FDA listed |
| Decitabine 50 mg/20mL | BluePoint | 1 vial | — | AP | FDA listed |
| Decitabine 50 mg/10mL | BluePoint | 1 vial | — | AP | FDA listed |
| decitabine 50 mg/10mL | Gland | 1 vial | — | AP | FDA listed |
| Decitabine 50 mg/20mL | Amneal | 1 vial | — | AP | FDA listed |
| Decitabine 50 mg/20mL | Meitheal | 1 vial | — | AP | FDA listed |
| Decitabine 50 mg/10mL | Bryant | 1 vial | — | AP | FDA listed |
| Decitabine 50 mg/10mL | Novadoz | 1 vial | — | AP | FDA listed |
| Decitabine 50 mg/10mL | Novadoz | 1 vial | — | AP | FDA listed |
| Decitabine 50 mg/10mL | Northstar | 1 vial | — | AP | FDA listed |
| Decitabine 50 mg/20mL | Nivagen | 1 vial | — | AP | FDA listed |
| Decitabine 50 mg | Ingenus | 1 vial | — | — | Discontinued |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Decitabine Injection — that fall in the same broad treatment class (antineoplastic - antimetabolites) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other oncology shortages
Decitabine Injection shortage FAQs
Is Decitabine Injection in shortage?
Which products are affected?
When will Decitabine Injection be available again?
Can I still get Decitabine somewhere?
What should I do if I take Decitabine Injection?
Still have a question about the Decitabine Injection shortage?
Ask a pharmacist about this shortage →View Decitabine Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.